Earnings Alerts

Zhejiang Supcon Technology (688777) Earnings Showcase an Increase in Net Income, R&D Expenses Meet Expectations

  • SUPCON’s FY R&D (Research and Development) Expenses have met expectations.
  • The total value of R&D expenses amounted to 907.8 million yuan, which was very close to the estimated 910 million yuan.
  • The company’s net income has increased significantly, showing a growth of +38.08%.
  • Investor sentiment is positive, with 30 buys, 1 hold and no sells.

A look at Zhejiang Supcon Technology Smart Scores

FactorScoreMagnitude
Value2
Dividend3
Growth5
Resilience5
Momentum2
OVERALL SMART SCORE3.4

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Analysts using the Smartkarma Smart Scores have assessed Zhejiang Supcon Technology’s long-term outlook, with the company scoring high in Growth and Resilience, indicating a positive trajectory for the future. Zhejiang Supcon Technology has received a strong score of 5 in both growth potential and resilience, showcasing its ability to expand and withstand market challenges effectively.

While Zhejiang Supcon Technology scored lower in Value and Momentum, with scores of 2 and 2 respectively, the company’s above-average scores in Growth and Resilience position it well for continued success in the industrial automation sector. Additionally, a moderate score of 3 in Dividend suggests a stable dividend payout policy for investors looking for income.

Zhejiang Supcon Technology Co., Ltd. specializes in manufacturing and distributing industrial automation control products such as distributed control systems and programmable logic controllers. With a global market presence, Zhejiang Supcon Technology aims to provide innovative solutions to enhance industrial processes and automation efficiency for its customers worldwide.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars